Sign in

CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company

ProPhase Labs, Inc.

Sign in to watch
Ticker
PRPH
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
232577138
Phone
(215) 345-0919
Business address
711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
Former names
QUIGLEY CORP
  1. 4/A Open-market buy Director bought 14,248 shares at an average $1.55 ($22,018)
  2. 4/A Open-market buy Director bought 35,752 shares at $1.30 ($46,478)
  3. 4 Grant or award Director acquired 14,248 shares (grant or award)
  4. 4 Grant or award Director acquired 35,752 shares (grant or award)
  5. 4 Grant or award Director acquired 145,309 shares (grant or award)
  6. 4 Grant or award Director acquired 204,691 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Director acquired 200,000 shares (grant or award)
  9. 4 Open-market buy See Remarks bought 200,000 shares at $1.30 ($260,000)
  10. 4 Open-market buy CEO & Chairman bought 210,000 shares at an average $1.35 ($283,395)
  11. 4 Grant or award Director acquired 3,147 shares (grant or award)
  12. 4 Grant or award Director acquired 6,295 shares (grant or award)
  13. 4 Grant or award Director acquired 6,295 shares (grant or award)
  14. 4 Grant or award Director acquired 6,295 shares (grant or award)
  15. 4 Grant or award Director acquired 6,295 shares (grant or award)
  16. 4 Grant or award CEO & Chairman acquired 100,000 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy 10% owner bought 64,746 shares at an average $1.34 ($86,676)
  19. 4 Open-market buy 10% owner bought 284,885 shares at an average $1.30 ($370,343)
  20. 4 Open-market buy 10% owner bought 16,900 shares at $1.40 ($23,621)

Page 5 of 11 · 215 filings